BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1657311)

  • 1. Evidence that a proconvulsant action of lithium is mediated by inhibition of myo-inositol phosphatase in mouse brain.
    Tricklebank MD; Singh L; Jackson A; Oles RJ
    Brain Res; 1991 Aug; 558(1):145-8. PubMed ID: 1657311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular myo-inositol antagonizes lithium-induced suppression of rearing behaviour in rats.
    Kofman O; Belmaker RH
    Brain Res; 1990 Nov; 534(1-2):345-7. PubMed ID: 1963564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
    Vadnal R; Parthasarathy R
    Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation.
    Faraci WS; Zorn SH; Bakker AV; Jackson E; Pratt K
    Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):369-74. PubMed ID: 8387266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of lithium isotopes on the myo-inositol 1-phosphatase reaction in rat brain, liver, and testes.
    Parthasarathy R; Parthasarathy L; Ramesh TG; Devi CS; Vadnal RE
    Life Sci; 1992; 50(19):1445-50. PubMed ID: 1315412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that inositol 1-phosphate in brain of lithium-treated rats results mainly from phosphatidylinositol metabolism.
    Ackermann KE; Gish BG; Honchar MP; Sherman WR
    Biochem J; 1987 Mar; 242(2):517-24. PubMed ID: 3036092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain.
    Hallcher LM; Sherman WR
    J Biol Chem; 1980 Nov; 255(22):10896-901. PubMed ID: 6253491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-proliferative effect of lithium chloride on melanoma cells and its reversion by myo-inositol.
    Nordenberg J; Panet C; Wasserman L; Malik Z; Fuchs A; Stenzel KH; Novogrodsky A
    Br J Cancer; 1987 Jan; 55(1):41-6. PubMed ID: 3028460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of brain myo-inositol levels in rats increases latency to lithium-pilocarpine seizures.
    Kofman O; Sherman WR; Katz V; Belmaker RH
    Psychopharmacology (Berl); 1993; 110(1-2):229-34. PubMed ID: 7870890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the putative lithium mimetic ebselen on pilocarpine-induced neural activity.
    Singh N; Serres F; Toker L; Sade Y; Blackburn V; Batra AS; Saiardi A; Agam G; Belmaker RH; Sharp T; Vasudevan SR; Churchill GC
    Eur J Pharmacol; 2020 Sep; 883():173377. PubMed ID: 32687920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lithium on phosphoinositide metabolism in vivo.
    Sherman WR; Gish BG; Honchar MP; Munsell LY
    Fed Proc; 1986 Oct; 45(11):2639-46. PubMed ID: 3019784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myo-inositol attenuates two specific behavioral effects of acute lithium in rats.
    Kofman O; Belmaker RH; Grisaru N; Alpert C; Fuchs I; Katz V; Rigler O
    Psychopharmacol Bull; 1991; 27(3):185-90. PubMed ID: 1775587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo 31P NMR spectroscopy of agonist-stimulated phosphatidylinositol metabolism in cat brain.
    Renshaw PF; Schnall MD; Leigh JS
    Magn Reson Med; 1987 Mar; 4(3):221-6. PubMed ID: 3033424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the effects of lithium on phosphatidylinositol (PI) cycle activity in human muscarinic m1 receptor-transfected CHO cells.
    Atack JR; Prior AM; Griffith D; Ragan CI
    Br J Pharmacol; 1993 Oct; 110(2):809-15. PubMed ID: 8242255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dephosphorylation pathway of D-myo-inositol 1,3,4,5-tetrakisphosphate in rat brain.
    Erneux C; Delvaux A; Moreau C; Dumont JE
    Biochem J; 1987 Nov; 247(3):635-9. PubMed ID: 2827634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that lithium alters phosphoinositide metabolism: chronic administration elevates primarily D-myo-inositol-1-phosphate in cerebral cortex of the rat.
    Sherman WR; Leavitt AL; Honchar MP; Hallcher LM; Phillips BE
    J Neurochem; 1981 Jun; 36(6):1947-51. PubMed ID: 6264039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation by inositol of cholinergic- and serotonergic-induced seizures in lithium-treated rats.
    Williams MB; Jope RS
    Brain Res; 1995 Jul; 685(1-2):169-78. PubMed ID: 7583243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression.
    Kofman O; Belmaker RH
    Biol Psychiatry; 1993 Dec; 34(12):839-52. PubMed ID: 8110911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic dietary lithium induces increased levels of myo-inositol-1-phosphatase activity in rat cerebral cortex homogenates.
    Renshaw PF; Joseph NE; Leigh JS
    Brain Res; 1986 Aug; 380(2):401-4. PubMed ID: 3019470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin-releasing hormone reduces myo-inositol content in rat cerebellum pretreated with lithium.
    Miyamoto Y; Kikkawa R; Hatanaka I; Yasuda H; Terada M; Yamashita M; Shigeta Y
    J Neurochem; 1987 Jul; 49(1):88-91. PubMed ID: 3035101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.